Details of the Drug-Related molecule(s) Expression Atlas
General Information of Drug (ID: DM81DTC)
Drug Name | ||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
6-(benzenesulfonyl)-2,3-dihydropyridazin-3-one; 141060-78-8; 3(2H)-Pyridazinone, 6-(phenylsulfonyl)-; AC1Q6GZS; CHEMBL74814; SCHEMBL7295107; BDBM16442; ZICCKDUVBPQRQT-UHFFFAOYSA-N; MolPort-007-599-834; ZINC11536236; AKOS001782098; MCULE-8830355611; NE56517; 6-phenylsulfonylpyridazin-2H-3-one, 1; 6-phenylsulfonyl-3-oxo-2,3-dihydropyridazine; EN300-72670
|
|||||||||||||||||||
Indication |
|
|||||||||||||||||||
Cross-matching ID | ||||||||||||||||||||
Molecule(s) Related to This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
The Expression Level of Molecule(s) in Normal Tissue of Major ADME-Related Organs
|
||||||||||||||||||||||||||
Molecule Expression Atlas in Normal Tissue of Major ADME-related organs | ||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
The Expression Level of Molecule(s) between Disease Section and Healthy Individual Tissue
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas between Disease Section and Healthy Individual Tissue | ||||||||||||||||||||||||